IMS HEALTH, INC. 
By IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, plans to announce first-quarter financial results after the market closes on Wednesday, April 18, 2007. Executive management will review the company's performance during a conference call with analysts at 5:00 p.m. EDT on April 18.
Participants may access the call via the following telephone numbers:
1-800-246-9120 (U.S. and Canada)
1-415-908-4708 (International)A replay will be available beginning at 7:30 p.m. EDT on April 18 until 7:30 p.m. EDT on April 25 by dialing:
1-800-633-8284 (U.S. and Canada)
1-402-977-9140 (International)
Reservation number to access playback: 21333938To listen to a live Webcast of the conference call, go to http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124& eventID=1520002. (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) A replay of the presentation will be available at the site for seven days following the call.
A copy of IMS's earnings news release, and any other financial and statistical information presented during the analyst conference call, will be made available in the ?Investors? area of IMS's website at http://www.imshealth.com.
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.0 billion in 2006 revenue and more than 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.
